Suchergebnisse - "Cariou, Bertrand"

PubPharm (22)

1

Urine-sample-derived human induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemia

enthalten in: Disease models & mechanisms | 2016

von Si-Tayeb, K. | Idriss, S. | Champon, B. | +7

2

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody

enthalten in: Circulation. Cardiovascular genetics | 2015

von Hopkins, P. | Defesche, J. | Fouchier, S. | +39

CommentIn: Circ Cardiovasc Genet. 2015 Dec;8(6):749-51. - PMID 26671969

3

PCSK9 Inhibition : Does Lipoprotein Size Matter?

enthalten in: Journal of the American Heart Association | 2015

von Si-Tayeb, K. | Cariou, B.

CommentOn: J Am Heart Assoc. 2015 Nov;4(11). pii: e002224. doi: 10.1161/JAHA.115.002224. - PMID 26586732

4

The loss-of-function PCSK9 p.R46L genetic variant does not alter glucose homeostasis

enthalten in: Diabetologia | 2015

von Bonnefond, A. | Yengo, L. | Le May, C. | +24

5

Role of PCSK9 beyond liver involvement

enthalten in: Current opinion in lipidology | 2015

von Cariou, B. | Si-Tayeb, K. | Le May, C.

6

Letter from Le May and Cariou regarding article, "Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechanisms"

enthalten in: Circulation | 2015

von Le May, C. | Cariou, B.

CommentOn: Circulation. 2014 Jul 29;130(5):431-41. - PMID 25070550

7

PCSK9-deficiency does not alter blood pressure and sodium balance in mouse models of hypertension

enthalten in: Atherosclerosis | 2015

von Berger, J. | Vaillant, N. | Le May, C. | +6

8

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2) : a randomised, double-blind, placebo-controlled trial

enthalten in: Lancet (London, England) | 2015

von Raal, F. | Stein, E. | Dufour, R. | +58

CommentIn: Lancet. 2015 Jan 24;385(9965):307-10. - PMID 25282517

9

Preserved adrenal function in fully PCSK9-deficient subject

enthalten in: International journal of cardiology | 2014

von Cariou, B. | Benoit, I. | Le May, C.

10

Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated doses of statins : rationale and design of the ODYSSEY COMBO I and II trials

enthalten in: BMC cardiovascular disorders | 2014

von Colhoun, H. | Robinson, J. | Farnier, M. | +6